Evaluation of 52 patients with Guillain Barré syndrome between 2015 and 2019 in Kocaeli, Turkey – An epidemiological study

Purpose. The primary purpose of this study is to evaluate the demographic, clinical and laboratory findings of patients with Guillain Barré syndrome (GBS), assess the clinical course, treatment outcomes and introduce GBS subgroups in Kocaeli, Turkey. Methods. Patients admitted to Kocaeli University...

Full description

Bibliographic Details
Main Authors: Buket Özkara, Yiğit Can Güldiken, Faik Budak, Özge Demirkol, Sedat Gül
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2020-12-01
Series:Romanian Journal of Neurology
Subjects:
Online Access:https://rjn.com.ro/articles/2020.4/RJN_2020_4_Art-10.pdf
_version_ 1818884233854189568
author Buket Özkara
Yiğit Can Güldiken
Faik Budak
Özge Demirkol
Sedat Gül
author_facet Buket Özkara
Yiğit Can Güldiken
Faik Budak
Özge Demirkol
Sedat Gül
author_sort Buket Özkara
collection DOAJ
description Purpose. The primary purpose of this study is to evaluate the demographic, clinical and laboratory findings of patients with Guillain Barré syndrome (GBS), assess the clinical course, treatment outcomes and introduce GBS subgroups in Kocaeli, Turkey. Methods. Patients admitted to Kocaeli University Neurology Clinic between 2015 and 2019 with a preliminary diagnosis of autoimmune inflammatory acute polyneuropathy were included. Demographic, clinical, laboratory data have been collected and analyzed prospectively. Prognosis was evaluated according to the sum of total scores from GBS disability scoring and Medical Research Council (MRC) scoring guidelines and the need for mechanical ventilation. For statistical analysis, IBM SPSS 20.0 (SPSS Inc., Chicago, IL, USA) was used. Results. 52 GBS patients were evaluated. Mean age at initial presentation was 50.33±17.2. 57.7% of the patients reported a recent disease, most common one being upper respiratory tract infection (URTI). Progression of the disease was reported as ascending in 39 patients (75%) and descending in 13 (25%). Muscle weakness was symmetrical in 46 patients (88.4%) and asymmetrical in 6 (11.6%). 30 out of 52 patients (57.6%) had an elevated erythrocyte sedimentation rate (ESR), 40 (76.9%) had leukocytosis, 11 (21.1%) had hyponatremia. Cerebrospinal fluid analysis of 39 patients revealed elevated protein levels in 32 of them (61.5%). 41 patients (78.8%) were treated with IVIG, 8 (15.4%) with plasmapheresis and IVIG, 2 patients (3.8%) were treated with plasmapheresis only. Conclusion. Our study revealed both consistent and contradicting findings to the literature that may lead further debate/research on the epidemiology of GBS.
first_indexed 2024-12-19T15:46:18Z
format Article
id doaj.art-68c44ec1dcd74fe8a2eaa76ddee7cfa8
institution Directory Open Access Journal
issn 1843-8148
2069-6094
language English
last_indexed 2024-12-19T15:46:18Z
publishDate 2020-12-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Journal of Neurology
spelling doaj.art-68c44ec1dcd74fe8a2eaa76ddee7cfa82022-12-21T20:15:19ZengAmaltea Medical Publishing HouseRomanian Journal of Neurology1843-81482069-60942020-12-0119428028510.37897/RJN.2020.4.10Evaluation of 52 patients with Guillain Barré syndrome between 2015 and 2019 in Kocaeli, Turkey – An epidemiological studyBuket Özkara0Yiğit Can Güldiken1Faik Budak2Özge Demirkol3Sedat Gül4Department of Neurology, Faculty of Medicine, Kocaeli University, TurkeyDepartment of Neurology, Faculty of Medicine, Kocaeli University, TurkeyDepartment of Neurology, Faculty of Medicine, Kocaeli University, TurkeyDepartment of Neurology, Faculty of Medicine, Kocaeli University, TurkeyDepartment of Neurology, Faculty of Medicine, Kocaeli University, TurkeyPurpose. The primary purpose of this study is to evaluate the demographic, clinical and laboratory findings of patients with Guillain Barré syndrome (GBS), assess the clinical course, treatment outcomes and introduce GBS subgroups in Kocaeli, Turkey. Methods. Patients admitted to Kocaeli University Neurology Clinic between 2015 and 2019 with a preliminary diagnosis of autoimmune inflammatory acute polyneuropathy were included. Demographic, clinical, laboratory data have been collected and analyzed prospectively. Prognosis was evaluated according to the sum of total scores from GBS disability scoring and Medical Research Council (MRC) scoring guidelines and the need for mechanical ventilation. For statistical analysis, IBM SPSS 20.0 (SPSS Inc., Chicago, IL, USA) was used. Results. 52 GBS patients were evaluated. Mean age at initial presentation was 50.33±17.2. 57.7% of the patients reported a recent disease, most common one being upper respiratory tract infection (URTI). Progression of the disease was reported as ascending in 39 patients (75%) and descending in 13 (25%). Muscle weakness was symmetrical in 46 patients (88.4%) and asymmetrical in 6 (11.6%). 30 out of 52 patients (57.6%) had an elevated erythrocyte sedimentation rate (ESR), 40 (76.9%) had leukocytosis, 11 (21.1%) had hyponatremia. Cerebrospinal fluid analysis of 39 patients revealed elevated protein levels in 32 of them (61.5%). 41 patients (78.8%) were treated with IVIG, 8 (15.4%) with plasmapheresis and IVIG, 2 patients (3.8%) were treated with plasmapheresis only. Conclusion. Our study revealed both consistent and contradicting findings to the literature that may lead further debate/research on the epidemiology of GBS.https://rjn.com.ro/articles/2020.4/RJN_2020_4_Art-10.pdfguillain barré syndromeacute inflammatory demyelinating polyneuropathy (aidp)acute motor axonal neuropathy (aman)acute motor-sensory axonal neuropathy (amsan)miller-fisher syndrome (mfs)
spellingShingle Buket Özkara
Yiğit Can Güldiken
Faik Budak
Özge Demirkol
Sedat Gül
Evaluation of 52 patients with Guillain Barré syndrome between 2015 and 2019 in Kocaeli, Turkey – An epidemiological study
Romanian Journal of Neurology
guillain barré syndrome
acute inflammatory demyelinating polyneuropathy (aidp)
acute motor axonal neuropathy (aman)
acute motor-sensory axonal neuropathy (amsan)
miller-fisher syndrome (mfs)
title Evaluation of 52 patients with Guillain Barré syndrome between 2015 and 2019 in Kocaeli, Turkey – An epidemiological study
title_full Evaluation of 52 patients with Guillain Barré syndrome between 2015 and 2019 in Kocaeli, Turkey – An epidemiological study
title_fullStr Evaluation of 52 patients with Guillain Barré syndrome between 2015 and 2019 in Kocaeli, Turkey – An epidemiological study
title_full_unstemmed Evaluation of 52 patients with Guillain Barré syndrome between 2015 and 2019 in Kocaeli, Turkey – An epidemiological study
title_short Evaluation of 52 patients with Guillain Barré syndrome between 2015 and 2019 in Kocaeli, Turkey – An epidemiological study
title_sort evaluation of 52 patients with guillain barre syndrome between 2015 and 2019 in kocaeli turkey an epidemiological study
topic guillain barré syndrome
acute inflammatory demyelinating polyneuropathy (aidp)
acute motor axonal neuropathy (aman)
acute motor-sensory axonal neuropathy (amsan)
miller-fisher syndrome (mfs)
url https://rjn.com.ro/articles/2020.4/RJN_2020_4_Art-10.pdf
work_keys_str_mv AT buketozkara evaluationof52patientswithguillainbarresyndromebetween2015and2019inkocaeliturkeyanepidemiologicalstudy
AT yigitcanguldiken evaluationof52patientswithguillainbarresyndromebetween2015and2019inkocaeliturkeyanepidemiologicalstudy
AT faikbudak evaluationof52patientswithguillainbarresyndromebetween2015and2019inkocaeliturkeyanepidemiologicalstudy
AT ozgedemirkol evaluationof52patientswithguillainbarresyndromebetween2015and2019inkocaeliturkeyanepidemiologicalstudy
AT sedatgul evaluationof52patientswithguillainbarresyndromebetween2015and2019inkocaeliturkeyanepidemiologicalstudy